Showing results (561-570 of 600) with videos related to

Sort By:
Pageof 60
Scandinavian Journal of Public Health|December 16, 2025
Reducing Europe's cancer and NCD burden through coordinated strategies on health determinants: The Joint Action on Cancer and other NCDs Prevention (JA-PreventNCD)Raffaella Bucciardini, Giovanna Elisa Calabrò, Johanna Cresswell-Smith, et al.
The New England Journal of Medicine|November 7, 2019
Prevention of Early Ventilator-Associated Pneumonia after Cardiac ArrestBruno François, Alain Cariou, Raphaël Clere-Jehl, et al.
Plos One|October 19, 2022
Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trialCaroline Diguisto, Amelie Le Gouge, Marie-Sara Marchand, et al.
Scientific Reports|October 15, 2016
Multimodal imaging of a humanized orthotopic model of hepatocellular carcinoma in immunodeficient miceTao Wu, Emilie Heuillard, Véronique Lindner, et al.
JAMA Dermatology|September 15, 2021
Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS TrialAnnabel Maruani, Elsa Tavernier, Olivia Boccara, et al.
Trials|June 28, 2018
Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase designAnnabel Maruani, Olivia Boccara, Didier Bessis, et al.
Heart Rhythm|April 8, 2022
Outcome of patients with early repolarization pattern and syncopeTsukasa Kamakura, Jean-Baptiste Gourraud, Nicolas Clementy, et al.
Oncogene|June 2, 2015
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutationsL Golmard, C Delnatte, A Laugé, et al.
BMC Oral Health|August 22, 2024
Developing the teledentistry acceptance survey for dentists - TAS-D: a Delphi studyMaha El Tantawi, Nour Ammar, Rodrigo Mariño, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 5, 2025
Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial)Thierry Lecomte, Bruno Giraudeau, Jean-Marc Phelip, et al.
Pageof 60